Pfizer and BioNTech received expanded U.S. FDA EUA of COVID-19 vaccine booster to include individuals 18 and older
On Nov. 19, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had expanded…
Pfizer provided U.S. Government with 10 million treatment courses of oral antiviral candidate to help combat COVID-19
On Nov. 18, 2021, Pfizer announced an agreement with the U.S. government to supply 10 million treatment courses…
CureVac published in Nature preclinical data of second-generation COVID-19 candidate
On Nov. 18, 2021, CureVac announced the online publication of the extended preclinical study of the second-generation vaccine…
Novavax and Serum Institute of India received Emergency Use Authorization for COVID-19 vaccine in the Philippines
On Nov. 17, 2021, Novavax and and Serum Institute of India announced that the Philippine Food and Drug…
Novavax confirmed European Medicines Agencyreview of COVID-19 vaccine filing for Conditional Marketing Authorization
On Nov. 17, 2021, Novavax announced that the European Medicines Agency (EMA) had begun its evaluation of an…
Zosano Pharma announced successful formulation of COVID-19 vaccine candidate on its microneedle patch system
On Nov. 17, 2021, Zosano Pharma announced that the Philippine Food and Drug Administration had granted emergency use…
PNNL-led study delivered road map of lung development
On Nov. 17, 2021, Pacific Northwest National Laboratory (PNNL) announced researchers had compiled the most comprehensive road map…
Biotechnology | COVID-19 | FDA | Life Science News | Therapeutics | Vaccine
GSK and Vir Biotechnology announced U.S. government agreements to purchase sotrovimab, a COVID-19 treatment
On Nov. 17, 2021, GlaxoSmithKline and Vir Biotechnology announced U.S. government contracts totalling approximately $1 billion (USD) to…
Imported Monkeypox case reported in Maryland
On Nov. 17, 2021, scientists at the Centers for Disease Control and Prevention (CDC) announced they were collaborating…
Pfizer submitted Emergency Use Authorization for novel COVID-19 oral antiviral candidate
On Nov. 16, 2021, Pfizer announced it had submitted an Emergency Use Authorization (EUA) of its investigational oral…
Pfizer and MPP announced agreement for COVID-19 oral antiviral treatment candidate to expand access in low- and middle-income countries
On Nov. 16, 2021, Pfizer and the Medicines Patent Pool (MPP), a United Nations-backed public health organization working…
EU to donate more than 70 million doses of Moderna COVID-19 vaccine to COVAX to fight COVID-19 pandemic in low income countries
On Nov. 16, 2021, an agreement was announced that enabled the European Union and European Economic Area countries…
Illumina and Genetic Alliance Launch $120 million globa initiative to increase equity and improve outcomes for families impacted by genetic disease
On Nov. 16, 2021, Illumina and Genetic Alliance announced the creation of the iHopeï¾™ Genetic Health program aimed…
Oxford / AstraZeneca vaccine reached two billion dose milestone
On Nov. 16, 2021, the University of Oxfordï¾’s and AstraZeneca announced that two billion doses of the ChAdOx1…
Novavax announced submission of Biologics License Application in South Korea for approval of NVX-CoV2373
On Nov. 15, 2021, Novavax and SK bioscience announced submission of a Biologics License Application (BLA) for Novavax’…
Health Canada authorized booster dose of Moderna’s COVID-19 vaccine in individuals 18 years of age and older
On Nov. 15, 2021, Moderna confirmed that Health Canada had authorized the use of a booster dose of…
Long-term study of children with COVID-19 began
On Nov. 15, 2021, a large, long-term study of the impacts of COVID-19 on children announced it had…
Oxford vaccine reached two billion dose milestone
On Nov. 15, 2021, AstraZeneca reported that 2 billion doses of the COVID-19 vaccine had been released for…
Regeneron antibody cocktail approved by European Commission to treat and prevent COVID-19
On Nov. 12, 2021, Regeneron announced that the European Commission (EC) had approved the casirivimab and imdevimab antibody…
Innovation Pharmaceuticals conducted full data analysis of phase 2 brilacidin COVID-19 trial results to support inclusion in Government-sponsored trials
On Nov. 12, 2021, Innovation Pharma announced the Company was conducting full data analysis of the Phase 2…
Primary endpoint met in COMET-TAIL Phase III trial evaluating intramuscular administration of sotrovimab for early treatment of COVID-19
On Nov. 12, 2021, GlaxoSmithKline and Vir Biotechnology announced headline data from the randomised, multi-centre, open-label COMET-TAIL Phase…
Leading Generic Drug Makers Unite to Pledge Capacity for Developing and Delivering Affordable COVID-19 Interventions as Pandemic Intensifies
On Sept. 21, 2021, the Medicines Patent Pool (MPP) announced that it had signed a licence agreement with…
Lincoln Children’s Zoo announced the deaths of three snow leopards due to COVID-19
On Nov. 12, 2021, Lincoln Children’s Zoo announced on Facebook that their three snow leopards: Ranney, Everest and…
Zipline, Pfizer and BioNTech paved way for automated, on-demand delivery of first mRNA COVID-19 vaccines in Ghana
On Nov. 11, 2021, Zipline, Pfizer and BioNTech announced that Zipline had successfully completed the first long-range drone…
CHMP recommends EU approval of Ronapreve to treat non-hospitalised COVID-19 patients and for prophylaxis of the disease
On Nov. 11, 2021, Roche announced that the European Medicines Agencyï¾’s (EMA) Committee for Medicinal Products for Human…
Innovation Pharmaceuticals announced topline results from phase 2 clinical trial of brilacidin for COVID-19
On Nov. 11, 2021, Innovation Pharma reported topline results from the Companyï¾’s Phase 2 clinical trial of Brilacidin…
University of Oxford’s Ebola vaccine began human trials
On Nov. 11, 2021, the University of Oxford began recruiting for a Phase I trial to test an…
Politicization and COVID-19 vaccine resistance in the U.S. widened during pandemic
On Nov. 10, 2021, a study by researchers at Georgia State University showed that the politicization of science…
Meridian Bioscience received FDA Emergency Use Authorization for Revogeneï¾® SARS-CoV-2 molecular assay
On Nov. 10, 2021, Meridian Bioscience announced that their Revogeneï¾® SARS-CoV-2 assay was granted Emergency Use Authorization by…
Global progress against measles threatened amidst COVID-19 pandemic
On Nov. 10, 2021, the World Health Organization (WHO) announced that while reported measles cases had fallen compared…